143 related articles for article (PubMed ID: 11745043)
21. Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy.
Gonzales E; Gardin A; Almes M; Darmellah-Remil A; Seguin H; Mussini C; Franchi-Abella S; Duché M; Ackermann O; Thébaut A; Habes D; Hermeziu B; Lapalus M; Falguières T; Combal JP; Benichou B; Valero S; Davit-Spraul A; Jacquemin E
JHEP Rep; 2023 Oct; 5(10):100844. PubMed ID: 37701337
[TBL] [Abstract][Full Text] [Related]
22. Low phospholipid-associated cholestasis and cholelithiasis.
Erlinger S
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S36-40. PubMed ID: 23141892
[TBL] [Abstract][Full Text] [Related]
23. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids.
Blázquez-García I; Guerrero L; Cacho-Navas C; Djouder N; Millan J; Paradela A; Carmona-Rodríguez L; Corrales FJ
J Proteome Res; 2024 Apr; 23(4):1433-1442. PubMed ID: 38488493
[TBL] [Abstract][Full Text] [Related]
24. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
Deleuze JF; Jacquemin E; Dubuisson C; Cresteil D; Dumont M; Erlinger S; Bernard O; Hadchouel M
Hepatology; 1996 Apr; 23(4):904-8. PubMed ID: 8666348
[TBL] [Abstract][Full Text] [Related]
25. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
[TBL] [Abstract][Full Text] [Related]
26. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
27. Tissue distribution of the human MDR3 P-glycoprotein.
Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P
Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
[TBL] [Abstract][Full Text] [Related]
30. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Wei G; Cao J; Huang P; An P; Badlani D; Vaid KA; Zhao S; Wang DQ; Zhuo J; Yin L; Frassetto A; Markel A; Presnyak V; Gandham S; Hua S; Lukacs C; Finn PF; Giangrande PH; Martini PGV; Popov YV
J Hepatol; 2021 Jun; 74(6):1416-1428. PubMed ID: 33340584
[TBL] [Abstract][Full Text] [Related]
31. A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT.
Tavian D; Degiorgio D; Roncaglia N; Vergani P; Cameroni I; Colombo R; Coviello DA
Dig Liver Dis; 2009 Sep; 41(9):671-5. PubMed ID: 19261551
[TBL] [Abstract][Full Text] [Related]
32. Liver transplantation in children with progressive familial intrahepatic cholestasis.
Englert C; Grabhorn E; Richter A; Rogiers X; Burdelski M; Ganschow R
Transplantation; 2007 Nov; 84(10):1361-3. PubMed ID: 18049123
[TBL] [Abstract][Full Text] [Related]
33. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
[TBL] [Abstract][Full Text] [Related]
34. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.
Lucena JF; Herrero JI; Quiroga J; Sangro B; Garcia-Foncillas J; Zabalegui N; Sola J; Herraiz M; Medina JF; Prieto J
Gastroenterology; 2003 Apr; 124(4):1037-42. PubMed ID: 12671900
[TBL] [Abstract][Full Text] [Related]
35. Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green.
Huang L; Vore M
Drug Metab Dispos; 2001 May; 29(5):634-7. PubMed ID: 11302927
[TBL] [Abstract][Full Text] [Related]
36. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
37. Paucity of Interlobular Bile Ducts in Multidrug-Resistant P-Glycoprotein 3 (MDR3) Deficiency.
Vij M; Valamparampil J; Shanmugum N; Reddy SM; Rajindrajith S; Rela M
Int J Surg Pathol; 2019 May; 27(3):343-347. PubMed ID: 30222019
[TBL] [Abstract][Full Text] [Related]
38. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis.
Rosmorduc O; Hermelin B; Poupon R
Gastroenterology; 2001 May; 120(6):1459-67. PubMed ID: 11313316
[TBL] [Abstract][Full Text] [Related]
39. Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate.
Boudechiche L; Tranchart H; Branchereau S; Davit-Spraul A; Laïnas P; Groyer-Picard MT; Weber A; Hadchouel M; Dagher I
Transplantation; 2015 Jan; 99(1):36-40. PubMed ID: 25340599
[TBL] [Abstract][Full Text] [Related]
40. [Progressive familial intrahepatic cholestasis presenting as liver failure].
Sangorrin Iranzo A; Iriondo Sanz M; Alvarez García L; Jara Vega P; Martín de Carpi J
An Pediatr (Barc); 2009 Dec; 71(6):510-3. PubMed ID: 19811957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
